Advanced glycation end products increase retinal vascular endothelial growth factor expression.
Open Access
- 15 March 1998
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 101 (6), 1219-1224
- https://doi.org/10.1172/jci1277
Abstract
Advanced glycation end products (AGEs) are linked with the development of diabetic retinopathy; however, the pathogenic mechanisms are poorly defined. Vascular endothelial growth factor (VEGF) levels are increased in ischemic and nonischemic diabetic retina, and VEGF is required for the development of retinal and iris neovascularization. Moreover, VEGF alone can induce much of the concomitant pathology of diabetic retinopathy. In this study, we found that AGEs increased VEGF mRNA levels in the ganglion, inner nuclear, and retinal pigment epithelial (RPE) cell layers of the rat retina. In vitro, AGEs increased VEGF mRNA and secreted protein in human RPE and bovine vascular smooth muscle cells. The AGE-induced increases in VEGF expression were dose- and time-dependent, inhibited by antioxidants, and additive with hypoxia. Use of an anti-VEGF antibody blocked the capillary endothelial cell proliferation induced by the conditioned media of AGE-treated cells. AGEs may participate in the pathogenesis of diabetic retinopathy through their ability to increase retinal VEGF gene expression.Keywords
This publication has 28 references indexed in Scilit:
- An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.American Journal of Ophthalmology, 1997
- Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartineDiabetologia, 1997
- Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats.1997
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992
- Immunochemical detection of advanced glycosylation end products in vivo.Journal of Biological Chemistry, 1992
- Lipid peroxidation and retinopathy in streptozotocin-induced diabetesFree Radical Biology & Medicine, 1991
- Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.Proceedings of the National Academy of Sciences of the United States of America, 1991
- The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicingJournal of Biological Chemistry, 1991
- Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform ExtractionAnalytical Biochemistry, 1987
- High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules.Proceedings of the National Academy of Sciences of the United States of America, 1985